You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
春立醫療(688236.SH):擬以1750萬元收購舒捷醫療股權並對其進行增資

格隆匯2月17日丨春立醫療(688236.SH)公佈,根據公司戰略規劃和經營發展的需要,為實現業務優勢互補,拓寬公司的產品矩陣,公司與舒捷醫療股東徐林峯、股東陳協分別簽署了《股權轉讓協議》,與舒捷醫療及其股東簽署了《增資協議》,公司擬以人民幣1750萬元收購舒捷醫療股權並對其進行增資。其中,擬以人民幣1100萬元受讓徐林峯所持有的舒捷醫療59.045%的股權以及陳協所持有的舒捷醫療1.205%的股權,擬以人民幣650萬元對舒捷醫療進行增資,認購舒捷醫療650萬元新增註冊資本。本次交易完成後,舒捷醫療註冊資本增至2650萬元,公司將持有舒捷醫療70%的股權,資金來源為公司自有資金或自籌資金。

舒捷醫療是一家主要從事手術動力裝置的研發、生產和銷售的科技型企業,主要產品包括手術動力裝置整機及配件等,主要用於外科手術中對骨組織、軟組織的切除、磨削、鋸切、修整等,現有產品主要輔助於骨科手術。標的公司取得了電動骨鋸以及電動骨鑽的產品註冊證,擁有13項授權專利,同時取得了CE認證證書,本次交易為公司在國內市場競爭中奠定了優勢基礎,也為未來參與全球市場競爭提供了支撐。

本次交易完成後,公司將開展醫療手術動力裝置的研發、設計和製造的新業務,擬通過收購舒捷醫療股權並對其增資的方式持有其70%股權來開展新的業務。通過此次收購,公司將快速切入醫療手術動力裝置領域,實現新業務突破,促進骨科耗材業務協同發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account